M J Moore

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)

Percy, A. Oza, B. Clarke, 2013, Investigational New Drugs.

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

D. V. Von Hoff, M. Moore, H. Burris, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.